Andrew Dickinson
Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.
Andrew Dickinson
Andrew Dickinson
Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.
Overview
Career Highlights
RelSci Relationships
Number of Boards
Birthday
Age
Contact Data
Relationships
RelSci Relationships are individuals Andrew Dickinson likely has professional access to.
A relationship does not necessarily indicate a personal connection.
In The News
RelSci
November 2, 2020
RelSci
November 2, 2020
Nasdaq
October 29, 2020
FiercePharma
September 25, 2020
Nasdaq
September 23, 2020


Paths to Andrew Dickinson
Education
Class of 1996
Class of 1993
Career History
President, Treasurer & Director
2020 - Current
President, Treasurer & Director
2020 - Current
Executive Vice President & Chief Financial Officer
2016 - Current
Transactions



Public Holdings

Other Affiliations
Andrew Dickinson is affiliated with Immunomedics Inc., Forty Seven, Inc., Gilead Sciences, Inc., Myogen, Inc., Lazard Ltd., Kirkland & Ellis LLP, Cooley LLP, Lazard Freres & Co. LLC, Lazard & Co., Ltd.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or
sponsored by Andrew Dickinson. The use of any trade name or trademark is for identification and
reference purposes only and does not imply any association with the trademark holder. The
Presence of Andrew Dickinson's profile does not indicate a business or promotional relationship of
any kind between RelSci and Andrew Dickinson.